(IntegrityPress.org) – Recently, the Food and Drug Administration (FDA) made an announcement regarding the nationwide recall of two Robitussin products due to contamination. The recall is because fungal microbes have been discovered in the medicine from Haleon, the drug’s producer.
The affected products, Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult, are part of eight nationwide shipments that are subject to recall. Widely used for flu and cold symptoms as well as allergy relief, these cough syrups are used a lot during the winter, which increases the risk of contamination.
Microbial contamination means that the products contain the presence of unwanted elements, such as bacteria, viruses, fungi, parasites, or any other type of external microbe within a product that is not supposed to be there. The specific nature of contamination in the cough syrups is not known.
Contamination is a concern throughout the production process of food and medicine, and avoiding it calls for strict hygiene and safety measures from start to finish.
While the company has not received adverse reaction reports linked to the recall, people with compromised immune systems face potentially severe health issues if exposed, including death or hospitalization from conditions like fungemia or fungal infection, if they use the contaminated cough syrups.
For those not immunocompromised, the likelihood of adverse reactions is low, but Haleon said in their statement that there is always a possibility for anybody to have an adverse reaction. They are actively communicating with distributors and customers, offering guidance on the proper steps for returning or throwing away the recalled products.
Consumers possessing these cough syrups are strongly advised to discontinue usage immediately and seek advice from a healthcare provider if any adverse events occur. Any concerns or inquiries regarding the recall can be directed to Haleon’s Consumer Relations team through their website or via email at [email protected].
Copyright 2024, IntegrityPress.org
